Persones / Equip Humà

Guillermo Chantada

Buscador de publicacions

Publicacions

  • Francis JH, Schaiquevich P, Buitrago E, Del Sole MJ, Zapata G, Croxatto JO, Marr BP, Brodie SE, Berra A, Chantada G and Abramson DH.

    Local and Systemic Toxicity of Intravitreal Melphalan for Vitreous Seeding in Retinoblastoma A Preclinical and Clinical Study

    Ophthalmology . 121(9): 1810-1817. Nº de cites: 104

    [doi:10.1016/j.ophtha.2014.03.028]

  • Moreno F, Sinaki B, Fandiño A, Dussel V, Orellana L and Chantada G.

    A Population-Based Study of Retinoblastoma Incidence and Survival in Argentine Children

    PEDIATRIC BLOOD & CANCER . 61(9): 1610-1615. Nº de cites: 36

    [doi:10.1002/pbc.25048]

  • Grigorovski N, Lucena E, Mattosinho C, Parareda A, Ferman S, Català-Mora J and Chantada G.

    Use of intra-arterial chemotherapy for retinoblastoma: results of a survey

    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY . 7(4): 726-730. Nº de cites: 42

    [doi:10.3980/j.issn.2222-3959.2014.04.26]

  • Chantada G, Fandiño AC, Schvartzman E, Raslawski E, Schaiquevich P and Manzitti J.

    Impact of Chemoreduction for Conservative Therapy for Retinoblastoma in Argentina

    PEDIATRIC BLOOD & CANCER . 61(5): 821-826. Nº de cites: 29

    [doi:10.1002/pbc.24857]

  • Taich P, Ceciliano A, Buitrago E, Sampor C, Fandino A, Villasante F, Lucena E, Romero L, Chantada G and Schaiquevich P.

    Clinical Pharmacokinetics of Intra-arterial Melphalan and Topotecan Combination in Patients with Retinoblastoma

    Ophthalmology . 121(4): 889-897. Nº de cites: 40

    [doi:10.1016/j.ophtha.2013.10.045]

  • Ottaviani D, Parma D, Giliberto F, Ferrer M, Fandino A, Davila MT, Chantada G and Szijan I.

    Spectrum of RB1 Mutations in Argentine Patients: 20-years Experience in the Molecular Diagnosis of Retinoblastoma

    OPHTHALMIC GENETICS . 34(4): 189-198. Nº de cites: 10

    [doi:10.3109/13816810.2012.755553]

  • Chantada G, Sampor C, Bosaleh A, Solernou V, Fandiño A and de Dávila MT.

    Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients.

    JAMA OPHTHALMOLOGY . 131(9): 1127-1134. Nº de cites: 26

    [doi:10.1001/jamaophthalmol.2013.260]

  • Laurent VE, Sampor C, Solernou V, Rossi J, Gabri M, Eandi-Eberle S, de Davila MT, Alonso DF and Chantada G.

    Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA

    EUROPEAN JOURNAL OF CANCER . 49(13): 2892-2899. Nº de cites: 23

    [doi:10.1016/j.ejca.2013.04.021]

  • Chantada G, Luna-Fineman S, Sitorus RS, Kruger M, Israels T, Leal-Leal C, Bakhshi S, Qaddoumi I, Abramson DH and Doz F.

    SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries

    PEDIATRIC BLOOD & CANCER . 60(5): 719-727. Nº de cites: 56

    [doi:10.1002/pbc.24468]

  • Schaiquevich P, Ceciliano A, Millan N, Taich P, Villasante F, Fandino AC, Dominguez J and Chantada G.

    Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma

    PEDIATRIC BLOOD & CANCER . 60(5): 766-770. Nº de cites: 43

    [doi:10.1002/pbc.24356]